Occlusion properties of prosthetic contact lenses for the treatment of amblyopia.
BACKGROUND
The efficacy of opaque contact lenses as occlusion therapy for amblyopia has been established in the literature. Prosthetic contact lenses use similar tints to improve cosmesis in scarred or deformed eyes and may be an alternative in occlusion therapy. To test this idea, we determined the degree of vision penalization elicited by prosthetic contact lenses and their effect on peripheral fusion.


METHODS
We tested 19 CIBA Vision DuraSoft 3 Prosthetic soft contact lenses with varying iris prints, underprints, and opaque pupil sizes in 10 volunteers with best-corrected Snellen distance visual acuity of 20/20 or better in each eye. Snellen visual acuity and peripheral fusion using the Worth 4-Dot test at near were measured on each subject wearing each of the 19 lenses.


RESULTS
Results were analyzed with 3-factor analysis of variance. Mean visual acuity through the various lenses ranged from 20/79 to 20/620. Eight lenses allowed preservation of peripheral fusion in 50% or more of the subjects tested. Iris print pattern and opaque pupil size were significant factors in determining visual acuity (p < 0.05).


CONCLUSIONS
Sufficient vision penalization can be achieved to make occlusion with prosthetic contact lenses a viable therapy for amblyopia. The degree of penalization can be varied and different iris print patterns and pupil sizes, using peripheral fusion, can be preserved with some lenses. Prosthetic contact lenses can be more cosmetically appealing and more tolerable than other amblyopia treatment modalities. These factors may improve compliance in occlusion therapy.
Collins
Randall S
RS
Wilford Hall Medical Center, Lackland AFB, San Antonio, Texas 78236, USA.
McChesney
Megan E
ME
McCluer
Craig A
CA
Schatz
Martha P
MP
D000328:Adult; D000550:Amblyopia / Q000503:physiopathology* / Q000628:therapy*; D000704:Analysis of Variance; D003116:Color; D003263:Contact Lenses, Hydrophilic; D003357:Cosmetic Techniques; D004867:Equipment Design; D006801:Humans; D007498:Iris; D011680:Pupil; D016896:Treatment Outcome; D014792:Visual Acuity